Rama Modali

4.9k citations

26 papers · 4.0k indexed · 2 hit papers · h-index 15

Impact in

Oncology top 1%
- Cancer-related Molecular Pathways
Cancer Research top 2%
- Cancer Genomics and Diagnostics

Papers in

Oncology 8
- Cancer-related Molecular Pathways 3
Toxicology 1

Co-authors: Curtis C. Harris Stephen Baylin Francis S. Collins Nancy E. Davidson Peter Devilee Bert Vogelstein J. Milburn Jessup Karen R. Cleary
Journals: Blood (2 papers)Carcinogenesis (2 papers)Environmental Health Perspectives (2 papers)International Journal of Cancer (2 papers)Epidemiology (2 papers)
Partner nations: United States India Australia

In The Last Decade

Rama Modali

25 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis 1994 · 644 citations

Peers

Countries citing papers authored by Rama Modali

Since Specialization

Citations

This map shows the geographic impact of Rama Modali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rama Modali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rama Modali more than expected).

Fields of papers citing papers by Rama Modali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rama Modali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rama Modali. The network helps show where Rama Modali may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rama Modali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rama Modali Line = papers co-authored together Rama Modali links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mutational landscape of BRCA gene mutations in Indian breast cancer patients: retrospective insights from a diagnostic lab SHILAP Revista de lepidopterología ·Katya Rachkova, Adrien Tessanne, สิตาพัชร์ ห้องสวัสดิ์, Rama Modali, Kishor Bhatia, Bhawna Dubey	2024	1
2	A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications BMC Bioinformatics ·Atsuhi Tabata, E.M. Gregores, Joseph McDermott, Mrunal Sontakke, Peter Carr, Neha Biyani, Rama Modali, Jean‐Philippe Richard, Paul-Gerhard Kanis, Kishor Bhatia	2021	5
3	A functional SNP in MRPL43 modulates lung cancer susceptibility and survival through alternative splicing of its isoforms Journal of Thoracic Oncology ·Andrew C. McClary, Jaime L Marquis, Jessica K. Roberts, Ana I. Robles, C. DE BRUIN, Majda Haznadar, Dominic Esposito, Kent E. Taylor, Khan Ma, Rama Modali, Hirokazu Okayama, Kouya Shiraishi, D. Ben Rees., Takashi Kohno, Bríd M. Ryan	2016	1
4	Effect modification by transferrin C2 polymorphism on lead exposure, hemoglobin levels, and IQ NeuroToxicology ·Ananya Roy, Adrienne S. Ettinger, Howard Hu, David Bellinger, Joel Schwartz, Rama Modali, Robert O. Wright, Kavitha Palaniappan, Kalpana Balakrishnan	2013	14
5	Hemoglobin, Lead Exposure, and Intelligence Quotient: Effect Modification by the DRD2 Taq IA Polymorphism Environmental Health Perspectives ·Ananya Roy, Howard Hu, David C. Bellinger, Bhramar Mukherjee, Rama Modali, Thang Phi, Joel Schwartz, Robert O. Wright, Adrienne S. Ettinger, Darren Paul Foster, Kalpana Balakrishnan	2010	30
6	Lead Exposure, Hemoglobin and Intelligence Quotient: Effect Modification by Dopamine Receptor D2 Taq IA Polymorphism Among Children in Chennai, India Epidemiology ·Ananya Roy, David Bellinger, Howard Hu, Rama Modali, Joel Schwartz, Robert Wright, Darren Paul Foster, Kalpana Balakrishnan	2009	1
7	Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression International Journal of Cancer ·Kishor Bhatia, James J. Goedert, Rama Modali, Liliana Preiss, Leona W. Ayers	2009	111
8	Merkel cell polyomavirus is not detected in mesotheliomas Journal of Clinical Virology ·Kishor Bhatia, Rama Modali, James J. Goedert	2009	15
9	Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial Cancer Causes & Control ·Gwen Murphy, Leah B. Sansbury, Amanda J. Cross, Rachael Z. Stolzenberg‐Solomon, Adeyinka O. Laiyemo, Paul S. Albert, Zhuoqiao Wang, Arthur Schatzkin, Teresa A. Lehman, Pedro Iñaki Sagasti, Rama Modali, Elaine Lanza	2008	9
10	Dopamine D₂ receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial International Journal of Cancer ·Gwen Murphy, Amanda J. Cross, Liégie Alher Marques, Andrew W. Bergen, Adeyinka O. Laiyemo, Paul S. Albert, Zhuoqiao Wang, Binbing Yu, Teresa A. Lehman, Pedro Iñaki Sagasti, Rama Modali, Arthur Schatzkin, Elaine Lanza	2008	16
11	Polynucleotide kinase 3′ phosphatase variant, dietary variables and risk of adenoma recurrence in the Polyp Prevention Trial European Journal of Cancer Prevention ·Gwen Murphy, Liégie Alher Marques, Andrew W. Bergen, Zhuoqiao Wang, Arthur Schatzkin, Teresa A. Lehman, Pedro Iñaki Sagasti, Rama Modali, Elaine Lanza	2008	1
12	Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer Cancer Letters ·Luke D. Ratnasinghe, Christian C. Abnet, You‐Lin Qiao, Rama Modali, Rachael Z. Stolzenberg‐Solomon, Zhiwei Dong, Sanford M. Dawsey, Steven D. Mark, Philip R. Taylor	2004	51
13	FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia Blood ·Thomas S. Lin, Ian W. Flinn, Rama Modali, Teresa A. Lehman, Jennifer Webb, Marcus Vaahto, Mollie E. Moran, Margaret S. Lucas, Sherif S. Farag, John C. Byrd	2004	53
14	FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia Blood ·Sherif S. Farag, Ian W. Flinn, Rama Modali, Teresa A. Lehman, Donn C. Young, John C. Byrd	2003	155
15	β2-Chimaerin Is a High Affinity Receptor for the Phorbol Ester Tumor Promoters Journal of Biological Chemistry ·Marı́a J. Caloca, Nieves Fernández, Nancy E. Lewin, Chia-Sheng Cheng, Rama Modali, Peter M. Blumberg, Marcelo G. Kazanietz	1997	88
16	Detection of K-rasOncogene Mutations by Polymerase Chain Reaction-Based Ligase Chain Reaction Analytical Biochemistry ·Teresa A. Lehman, Frank Scott, Michael Seddon, Karen Kelly, Edward C. Dempsey, Vincent L. Wilson, James L. Mulshine, Rama Modali	1996	22
17	p53 Mutations in human immortalized epithelial cell lines Carcinogenesis ·Teresa A. Lehman, Rama Modali, Petra Boukamp, Valentina Rabie, William P. Bennett, Judith A. Welsh, Robert A. Metcalf, Martha R. Stampfer, Norbert E. Fusenig, Eileen M. Rogan, Curtis C. Harris	1993	375
18	Oncogenes and Tumor Suppressor Genes Involved in Human Lung Carcinogenesis PubMed ·Curtis C. Harris, Roger R. Reddel, Rama Modali, Teresa A. Lehman, S. Peruvazhuthi, Randal Esteban Blanco Navarro, Haruhiko Sugimura, Ainsley Weston, Andréa Pfeifer	1990	4
19	Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls Carcinogenesis ·Haruhiko Sugimura, Neil E. Caporaso, Gail L. Shaw, Rama Modali, Frank J. Gonzalez, Robert N. Hoover, James H. Resau, Benjamin F. Trump, A Weston, Curtis C. Harris	1990	41
20	Mutations in the p53 gene occur in diverse human tumour types Nature ·Janice Nigro, Suzanne J. Baker, Antonette C. Preisinger, J. Milburn Jessup, S Smith, Karen R. Cleary, Siyi Li, Nancy E. Davidson, Stephen Baylin, Peter Devilee, Thomas W. Glover, Francis S. Collins, T.T. Lamark, Rama Modali, Curtis C. Harris, Bert Vogelstein Hit paper breakdown →	1989	2370

About Rama Modali

Rama Modali is a scholar working on Oncology, Toxicology, Health, Toxicology and Mutagenesis, Cancer Research and Genetics, having authored 26 papers that have together received 4.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (3 papers), Cancer-related Molecular Pathways (3 papers), Heavy Metal Exposure and Toxicity (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Trace Elements in Health (2 papers), Computational Drug Discovery Methods (2 papers), Molecular Biology Techniques and Applications (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (827 citations), Biotechnology (393 citations), Pathology and Forensic Medicine (559 citations) and Molecular Biology (1.8k citations). Rama Modali has collaborated with scholars based in United States, India and Australia. Frequent co-authors include Curtis C. Harris, Stephen Baylin, Francis S. Collins, Nancy E. Davidson, Peter Devilee, Bert Vogelstein, J. Milburn Jessup, Karen R. Cleary, Antonette C. Preisinger and Thomas W. Glover. Their work appears in journals such as Blood, Carcinogenesis, Environmental Health Perspectives, International Journal of Cancer and Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact